These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 501919)

  • 21. [Letter: Diffusion of cephazolino in cerebrospinal fluid as a function of mode of administration. Human clinical and animal experimental data].
    Armengaud M; Auvergnat JC; Gleises A
    Nouv Presse Med; 1975 Mar; 4(9):668. PubMed ID: 1129131
    [No Abstract]   [Full Text] [Related]  

  • 22. [Transferability of cefozopran to cerebrospinal fluid in rabbits with meningitis caused by Staphylococcus aureus].
    Haruta T; Okura K; Kuroki S; Nikami H; Kobayashi Y
    Jpn J Antibiot; 1996 May; 49(5):517-21. PubMed ID: 8752865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of cefamandole in neonatal purulent meningitis caused by E. coli (author's transl)].
    Yamamoto T; Hirata S; Yokoi Y; Ohtani T; Hosoe A; Nishimura Y
    Jpn J Antibiot; 1981 Oct; 34(10):1410-5. PubMed ID: 7038185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental and clinical studies on the time-dependent transit into cerebrospinal fluid of antibiotics administered systemically (author's transl)].
    Sato J
    Neurol Med Chir (Tokyo); 1978 Nov; 18(10 2):753-63. PubMed ID: 82917
    [No Abstract]   [Full Text] [Related]  

  • 25. Penetration of cefuzoname into the cerebrospinal fluid of rabbits.
    Haruta T; Yamamoto H; Okura KE; Kuroki S; Kobayashi Y
    Antimicrob Agents Chemother; 1986 Jul; 30(1):157-60. PubMed ID: 3530123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental and clinical study of the biliary excretion of cefamandole (author's transl)].
    Brogard JM; Pinget M; Arnaud JP; Dorner M; Adloff M; Lavillaureix J
    Pathol Biol (Paris); 1981 Jan; 29(1):25-30. PubMed ID: 7010273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of meningitides].
    Bender F
    Bibl Psychiatr Neurol; 1969; 139():635-47. PubMed ID: 4944736
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of meningitis during therapy with cefamandole.
    Aronoff SC; Thomford W; Bertino JS; Speck WT
    Pediatrics; 1981 May; 67(5):727-8. PubMed ID: 6973134
    [No Abstract]   [Full Text] [Related]  

  • 30. A pharmacokinetic analysis of ampicillin in the cerebrospinal fluid of rabbits with staphylococcal meningitis.
    Morikawa Y
    Jpn J Antibiot; 1981 Aug; 34(8):1178-84. PubMed ID: 7321196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics of cefamandole in rabbits].
    Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
    Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Penetration of aztreonam and ampicillin to cerebrospinal fluid in the concomitant administration to rabbits with Staphylococcus aureus meningitis].
    Okura K; Haruta T; Yamamoto H; Kuroki S; Kobayashi Y
    Jpn J Antibiot; 1985 Nov; 38(11):3378-86. PubMed ID: 4094069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid penetration after combined administration of cefotaxime and ampicillin to rabbits with staphylococcal meningitis.
    Kobayashi Y; Haruta T; Okura K
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():125-34. PubMed ID: 6094431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Laboratory and clinical studies of cefamandole in children (author's transl)].
    Iwai N; Sasaki A; Futamura J; Miyazu M; Osuga T
    Jpn J Antibiot; 1979 Sep; 32(9):938-51. PubMed ID: 501921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the criteria used for the interruption of treatment in bacterial meningitis (persistent pleocytosis and hyperproteinorrhachia) (author's transl)].
    Manios S; Rousso I; Daniil A
    Ann Pediatr (Paris); 1979 Dec; 26(10):687-91. PubMed ID: 555607
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of bacterial meningitis with cefamandole].
    de Carvalho Filho EM; Costa E; Silva IC; Silva CP; Costa YA; Korzeniowski O; Sande M; Rocha H
    Rev Inst Med Trop Sao Paulo; 1978; 20(6):342-6. PubMed ID: 35821
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical evaluation of cefamandole in infants and children (author's transl)].
    Kuno K; Nishikawa K; Ogawa A; Yamaguchi H; Koide T; Kondo K
    Jpn J Antibiot; 1979 Sep; 32(9):952-5. PubMed ID: 387995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Penetration of antibiotics into the cerebrospinal fluid. Theoretical and practical aspects (author's transl)].
    Modai J
    Nouv Presse Med; 1980 Dec; 9(47):3615-20. PubMed ID: 6937071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Right and wrong ways to treat meningitis (author's transl)].
    Helwig H
    Monatsschr Kinderheilkd; 1982 May; 130(5):307-11. PubMed ID: 7110151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Haemophilus influenzae meningitis in patients treated with cefamandole.
    Chartrand SA; Marks MI; Roberts R; Jubelirer DP; Plunket DC
    J Pediatr; 1981 Jun; 98(6):1003-5. PubMed ID: 7229784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.